Efficacy and safety of traditional Chinese medicine external washing in the treatment of postoperative wound of diabetes complicated with anal fistula: Study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial

被引:3
作者
Kang, Jian [1 ]
Liu, Ya [2 ]
Peng, Sihan [2 ]
Tang, Xiao [3 ]
Liu, Lu [3 ]
Xie, Ziyan [3 ]
He, Yuchi [3 ]
Zhang, Xiyu [2 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Dept Anorectal, Chengdu, Peoples R China
[2] Hosp Chengdu Univ Tradit Chinese Med, TCM Regulating Metab Dis Key Lab Sichuan Prov, Chengdu, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Sch Clin Med, Chengdu, Peoples R China
关键词
postoperative diabetes with anal fistula; traditional Chinese medicine; external washing; randomized controlled trial; Jiedu Shengji decoction;
D O I
10.3389/fphar.2022.938270
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Anal fistula is one of the commonest ailments seen by anorectal surgeons as surgery is currently the preferred treatment for it. Diabetes mellitus is a risk factor that can lead to slow wound healing after anal fistula surgery. Because of the large postoperative wound surface of anal fistula, patients with diabetes can have an increased probability of wound infection, which makes it hard to heal. There is an extensive clinical experience for wound healing in traditional Chinese medicine (TCM). The Jiedu Shengji decoction (JSD) is a widely used external washing decoction in clinical practice. However, the current evidence on it is still insufficient. Therefore, we report this carefully designed clinical trial to assess the efficacy and safety of JSD in the treatment of postoperative wounds in diabetic patients with anal fistula. Methods and analysis: This study was designed to be a randomized, double-blind, placebo-controlled, multi-center clinical trial. There were 60 eligible participants who were randomized at a 1:1 ratio to the intervention and placebo groups. Both groups received the same standard treatment. The intervention group was given external washing decoction of TCM (JSD), while the placebo group was given the placebo made of excipients and flavoring agents. The main outcome measures include wound healing, distribution of wound pathogens, levels of inflammatory mediators, and blood glucose. The secondary outcome measures included lipids, the quality of the life evaluation scale (Short-Form Health Survey 36). Assessments were performed before the start of the study, at 1st, 2nd, 3rd, and 4th weeks after the intervention, and at 8th, 12th, and 16th follow-up weeks. Discussion: The clinical study we proposed will be the first randomized, double-blind, placebo-controlled, multi-center clinical trial study to assess the efficacy and safety of TCM external washing (JSD) in the treatment of postoperative wounds in diabetic patients with anal fistula. Ethics and dissemination: The Medical Ethics Committee of Hospital of Chengdu University of Traditional Chinese Medicine has reviewed this study protocol and gave its approval and consent on 17 March, 2022 (Ethical Review Number: 2022KL-018).
引用
收藏
页数:10
相关论文
共 50 条
  • [41] A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
    Wan, Yingying
    Yang, Jiaxi
    Ma, Tianyue
    Wang, Wenqian
    Wang, Haonan
    Sun, Wenting
    Ye, Wanting
    Yang, Lin
    Ren, Jianxun
    Kou, Qiuai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Liu, Ningning
    Wu, Chaojun
    Jia, Ru
    Cai, Guoxiang
    Wang, Yan
    Zhou, Lihong
    Ji, Qing
    Sui, Hua
    Zeng, Puhua
    Xiao, Haijuan
    Liu, Huaimin
    Huo, Jiege
    Feng, Yuanyuan
    Deng, Wanli
    Li, Qi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [43] Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial
    Lun-Chien Lo
    Chia-Yun Chen
    Shou-Tung Chen
    Hung-Chang Chen
    Tsung-Chieh Lee
    Cheng-Shyong Chang
    Trials, 13
  • [44] Efficacy and safety of Xuefu Zhuyu Granules combined with western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial
    Liu, Dong
    Zeng, Yunjie
    Liang, Peng
    Jiang, Yunlu
    An, Su
    Ren, Pengcheng
    MEDICINE, 2022, 101 (43) : E31235
  • [45] Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial
    Lo, Lun-Chien
    Chen, Chia-Yun
    Chen, Shou-Tung
    Chen, Hung-Chang
    Lee, Tsung-Chieh
    Chang, Cheng-Shyong
    TRIALS, 2012, 13
  • [46] Xin-Li-Fang efficacy and safety for patients with chronic heart failure: A study protocol for a randomized, double-blind, and placebo-controlled trial
    Liu, Tong
    Yao, Sijie
    Jiang, Wei
    Lan, Taohua
    Xu, Wenjing
    Cao, Haiming
    Yao, Ping
    Wang, Chao
    Lu, Weihui
    Chen, Xiankun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [47] The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial
    David N. Hager
    Michael H. Hooper
    Gordon R. Bernard
    Laurence W. Busse
    E. Wesley Ely
    Alpha A. Fowler
    David F. Gaieski
    Alex Hall
    Jeremiah S. Hinson
    James C. Jackson
    Gabor D. Kelen
    Mark Levine
    Christopher J. Lindsell
    Richard E. Malone
    Anna McGlothlin
    Richard E. Rothman
    Kert Viele
    David W. Wright
    Jonathan E. Sevransky
    Greg S. Martin
    Trials, 20
  • [48] The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial
    Hager, David N.
    Hooper, Michael H.
    Bernard, Gordon R.
    Busse, Laurence W.
    Ely, E. Wesley
    Fowler, Alpha A.
    Gaieski, David F.
    Hall, Alex
    Hinson, Jeremiah S.
    Jackson, James C.
    Kelen, Gabor D.
    Levine, Mark
    Lindsell, Christopher J.
    Malone, Richard E.
    McGlothlin, Anna
    Rothman, Richard E.
    Viele, Kert
    Wright, David W.
    Sevransky, Jonathan E.
    Martin, Greg S.
    TRIALS, 2019, 20 (1)
  • [49] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
  • [50] The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial
    Wang, Hui
    Mu, Wei
    Zhai, Jingbo
    Xing, Dongmei
    Miao, Shujie
    Wang, Jia
    Deng, Yueyi
    Wang, Niansong
    Chen, Hongyu
    Yang, Hongtao
    He, Xuehong
    Shang, Hongcai
    TRIALS, 2013, 14